Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Cancer Type/Condition:  Brain tumor, adult: General and other
Trial Status:  Active
Results 1-25 of 521 for your search:
Start Over
Correlation Between SV2A Expression in Tumour Tissue and Efficacy of Levetiracetam in Glioma Patients With Epilepsy
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: EPI-GLIO-LEV, NCT00454935
Comparison of 20% Mannitol and 3% Hypertonic Saline for Cerebral Relaxation During Elective Supratentorial Craniotomies
Phase: Phase IV
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: Study on cerebral relaxation, NCT01745081
Post-approval Study of NovoTTF-100A in Recurrent GBM Patients
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 22 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: EF-19, NCT01756729
Yellow 560 Microscope for Intraoperative Visualization of Fluorescein Stained Intracranial Lesions
Phase: Phase IV
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: GCBS-0003, NCT02028325
Efficacy Evaluation of Dotarem®-Enhanced MRI Compared to Gadovist®/Gadavist®-Enhanced MRI in the Diagnosis of Brain Tumors
Phase: Phase IV
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: DGD-44-058, NCT02034708
Effect of Perioperative Glucocorticoid Replacement on Prognosis of Surgical Patients With Sellar Lesions
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: WestChina-2013137, NCT02190994
Light Sedation or Intubated General Anesthesia in Patients With Brain Cancer Undergoing Craniotomy
Phase: Phase IV
Type: Supportive care, Treatment
Status: Active
Age: 19 and over
Sponsor: Other
Protocol IDs: OSU-12161, NCI-2014-01110, NCT02193568
1 Week Versus 6 Weeks of Levetiracetam in Surgical Brain Tumor Patients
Phase: Phase IV
Type: Supportive care
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: IRB201400876, NCT02334722
Gentamicin Treatment Prior to Schwannoma Surgery - Residual Function
Phase: Phase IV
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: VS-FT-01, NCT02379754
Gentamicin Treatment Prior to Schwannoma Surgery - No Residual Function
Phase: Phase IV
Type: Health services research, Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: VS-FT-02, NCT02415257
A Comparison of Remifentanil and Dexmedetomidine for Craniotomy Perioperative Hemodynamics and Postoperative Pain
Phase: Phase III, Phase II
Type: Supportive care
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: 10-1056, NCT01269918
Additive Homeopathy in Cancer Patients
Phase: Phase III, Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 5, NCT01509612
C11-Sodium Acetate PET/CT Imaging Evaluation in Brain Glioma, Post Therapy Necrosis and Pseudo-progression
Phase: Phase III, Phase II
Type: Diagnostic
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: AMIC-AC-003, NCT01961934
Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2014-00616, CALGB-A071102, A071102, U10CA180821, U10CA031946, NCT02152982
Vestibular Schwannoma - Radiosurgery or Expectation: V-REX.
Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: 2014/314, NCT02249572
The Effects of Gabapentin Premedication on Neurosurgery
Phase: Phase III, Phase II
Type: Supportive care
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: ky2013-008-01, NCT02306278
P2/3 Randomized Study of Toca 511 & Toca FC Versus SOC in Subjects Undergoing Surgery for Recurrent GBM/AA
Phase: Phase III, Phase II
Type: Treatment
Status: Approved-not yet active
Age: 18 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: Tg 511-15-01, NCT02414165
18F-fluorodeoxyglucose (18F-FDG) Positron Emission Tomography in Oncology
Phase: Phase III
Type: Diagnostic
Status: Active
Age: 19 to 90
Sponsor: Other
Protocol IDs: R05-0076, NCT00207298
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Pharmaceutical / Industry
Protocol IDs: 020221, NCT00045968
Radiation Therapy With or Without Temozolomide in Treating Patients With Anaplastic Glioma
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000582632, EORTC-26053, CAN-NCIC-CEC1, RTOG-0834, EORTC-22054, EUDRACT-2006-001533-17, SPRI-EORTC-26053, MERCK-EORTC-26053, MRC-BR14, COGNO-EORTC-26053, CEC1, NCT00626990
Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000654697, ECOG-E3F05, E3F05, NCT00978458
Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 50 and under
Sponsor: NCI, Other
Protocol IDs: AEWS1031, NCI-2011-02611, COG-AEWS1031, CDR0000687639, U10CA098543, NCT01231906
Fluorescence-guided Surgery for Low- and High-grade Gliomas
Phase: Phase III
Type: Treatment
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: IRB#10BN132, NCT01502280
Phase III Study Comparing 2 Brain Conformational Radiotherapy in Combination With Chemotherapy in the Treatment of Glioblastoma
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 08 TETE 01, NCT01507506
iMRI Guided Resection in Cerebral Glioma Surgery
Phase: Phase III
Type: Health services research, Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: XBR2011022, NCT01479686
Start Over